COX-2 inhibitory treatment in chronic lymphocytic leukemia: a preliminary clinical study. (Record no. 15054682)

MARC details
000 -LEADER
fixed length control field 01247 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514201101.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200411s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1042-8194
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1080/10428190410001663608
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kara, Ismail Oguz
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20041101
245 00 - TITLE STATEMENT
Title COX-2 inhibitory treatment in chronic lymphocytic leukemia: a preliminary clinical study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Leukemia & lymphoma
Date of publication, distribution, etc. Jul 2004
300 ## - PHYSICAL DESCRIPTION
Extent 1495-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Celecoxib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclooxygenase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Evaluation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Lymphocytic, Chronic, B-Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukocyte Count
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Proteins
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pilot Projects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision therapeutic use
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sahin, Berksoy
773 0# - HOST ITEM ENTRY
Title Leukemia & lymphoma
Related parts vol. 45
-- no. 7
-- p. 1495-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1080/10428190410001663608">https://doi.org/10.1080/10428190410001663608</a>
Public note Available from publisher's website

No items available.